Evaluation of a novel probiotic Bacillus coagulans (Ganeden BC30) cell wall and metabolites: Anti-infammatory and immune modulating effects in vitro.

Purpose of this study

This study was undertaken to evaluate whether the biological effects caused by the novel probiotic, spore-forming strain of Bacillus coagulans GBI-30 (PTA-6086, Ganeden BC30) were due to cell wall components alone, or whether secreted substances from the live bacteria had additional biological properties. This investigation was conducted to address specific aspects of the ongoing discussion as to whether probiotics only act via the cell walls, or whether they may provide different bioactive compounds when alive and metabolically active.

Poster (pdf)